Eindec Corporation Limited (SGX:42Z)
Singapore · Delayed Price · Currency is SGD 0.0240
-0.0180 (-42.86%)
At close: Aug 1, 2025
Orchard Therapeutics Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 13.63 | 13.73 | 15.9 | 25.88 | 16.84 | 20.4 | Upgrade | |
Revenue Growth (YoY) | 3.83% | -13.62% | -38.57% | 53.70% | -17.46% | 81.32% | Upgrade |
Cost of Revenue | 9.88 | 9.68 | 11.41 | 19.46 | 12.95 | 16.08 | Upgrade |
Gross Profit | 3.75 | 4.05 | 4.49 | 6.42 | 3.89 | 4.31 | Upgrade |
Selling, General & Admin | 3.92 | 4.22 | 4.43 | 4.15 | 4.37 | 4.6 | Upgrade |
Other Operating Expenses | 0.03 | 0.02 | -0.06 | -0.02 | -0.08 | -0.22 | Upgrade |
Operating Expenses | 3.87 | 4.16 | 4.48 | 4.22 | 4.28 | 4.41 | Upgrade |
Operating Income | -0.11 | -0.1 | 0.01 | 2.2 | -0.39 | -0.09 | Upgrade |
Interest Expense | -0.25 | -0.29 | -0.32 | -0.35 | -0.26 | -0.23 | Upgrade |
Interest & Investment Income | 0.03 | 0.03 | 0.03 | 0.02 | 0.04 | 0.04 | Upgrade |
Currency Exchange Gain (Loss) | - | - | 0.13 | 0.13 | 0.17 | 0.14 | Upgrade |
EBT Excluding Unusual Items | -0.33 | -0.37 | -0.15 | 2.01 | -0.45 | -0.14 | Upgrade |
Gain (Loss) on Sale of Assets | 0.21 | 0.21 | 0.05 | - | - | - | Upgrade |
Asset Writedown | - | - | - | -0.08 | - | - | Upgrade |
Other Unusual Items | 0 | 0 | 0.01 | -0.11 | 0.01 | 0.3 | Upgrade |
Pretax Income | -0.12 | -0.15 | -0.09 | 1.81 | -0.44 | 0.16 | Upgrade |
Income Tax Expense | 0.04 | 0.03 | 0.06 | -0.11 | 0.23 | 0.28 | Upgrade |
Earnings From Continuing Operations | -0.15 | -0.18 | -0.15 | 1.93 | -0.68 | -0.12 | Upgrade |
Minority Interest in Earnings | -0 | 0.03 | 0.37 | -0.31 | -0.28 | -0.49 | Upgrade |
Net Income | -0.06 | -0.15 | 0.21 | 1.62 | -0.95 | -0.61 | Upgrade |
Net Income to Common | -0.06 | -0.15 | 0.21 | 1.62 | -0.95 | -0.61 | Upgrade |
Net Income Growth | - | - | -86.76% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 125 | 108 | 108 | 108 | 108 | 108 | Upgrade |
Shares Outstanding (Diluted) | 125 | 108 | 108 | 108 | 108 | 108 | Upgrade |
Shares Change (YoY) | 16.70% | - | - | - | - | - | Upgrade |
EPS (Basic) | -0.00 | -0.00 | 0.00 | 0.02 | -0.01 | -0.01 | Upgrade |
EPS (Diluted) | -0.00 | -0.00 | 0.00 | 0.01 | -0.01 | -0.01 | Upgrade |
EPS Growth | - | - | -86.75% | - | - | - | Upgrade |
Free Cash Flow | 1.57 | 0.42 | 2.39 | 1.51 | -2.54 | 2.77 | Upgrade |
Free Cash Flow Per Share | 0.01 | 0.00 | 0.02 | 0.01 | -0.02 | 0.03 | Upgrade |
Gross Margin | 27.52% | 29.50% | 28.22% | 24.81% | 23.11% | 21.14% | Upgrade |
Operating Margin | -0.84% | -0.76% | 0.06% | 8.51% | -2.34% | -0.46% | Upgrade |
Profit Margin | -0.46% | -1.10% | 1.35% | 6.25% | -5.66% | -2.98% | Upgrade |
Free Cash Flow Margin | 11.48% | 3.09% | 15.06% | 5.83% | -15.06% | 13.57% | Upgrade |
EBITDA | 0.34 | 0.34 | 0.77 | 3.16 | 1.06 | 0.19 | Upgrade |
EBITDA Margin | 2.46% | 2.48% | 4.86% | 12.19% | 6.29% | 0.95% | Upgrade |
D&A For EBITDA | 0.45 | 0.44 | 0.76 | 0.95 | 1.45 | 0.29 | Upgrade |
EBIT | -0.11 | -0.1 | 0.01 | 2.2 | -0.39 | -0.09 | Upgrade |
EBIT Margin | -0.84% | -0.76% | 0.06% | 8.51% | -2.34% | -0.46% | Upgrade |
Effective Tax Rate | - | - | - | - | - | 175.16% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.